Crossref

1. The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors

- Zhi-Qin Li

- Chun-Ling Hu

- Ping Yu

- Xin-Yu Gu

- Jia-Jia Zhang

- Hua Li

- Hong-Yu Zhang

- Jun Lv

- Yan-Min Liu

- Qing-Lei Zeng

- Jing-Ya Yan

- Zu-Jiang Yu

- Yi Zhang

2. The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis

- Yi-Xiang Zheng

- Peng-Cheng Zhou

- Rong-Rong Zhou

- Xue-Gong Fan

3. Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

- Fardin Dolatimehr

- Hamidreza Karimi-Sari

- Mohammad Saeid Rezaee-Zavareh

- Seyed Moayed Alavian

- Bita Behnava

- Mohammad Gholami-Fesharaki

- Heidar Sharafi

4. Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma

- Mei Lu

- Jia Li

- Loralee B. Rupp

- Scott D. Holmberg

- Anne C. Moorman

- Philip R. Spradling

- Eyasu H. Teshale

- Yueren Zhou

- Joseph A. Boscarino

- Mark A. Schmidt

- Lois E. Lamerato

- Connie Trinacty

- Sheri Trudeau

- Stuart C. Gordon

5. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals

- Khashayar Hesamizadeh

- Heidar Sharafi

- Mohammad Saeid Rezaee-Zavareh

- Bita Behnava

- Seyed Moayed Alavian